Πέμπτη 3 Μαΐου 2018

Adjuvant sunitinib for high-risk-resected renal cell carcinoma: a meta-analysis of ASSURE and S-TRAC trials.

https:--academic.oup.com-images-oup_pubm Related Articles

Adjuvant sunitinib for high-risk-resected renal cell carcinoma: a meta-analysis of ASSURE and S-TRAC trials.

Ann Oncol. 2017 04 01;28(4):898-899

Authors: Gyawali B, Ando Y

PMID: 27993814 [PubMed - indexed for MEDLINE]



https://ift.tt/2HMkhUn

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου